Morgan Stanley analyst Bob Huang maintained a Hold rating on Marsh & Mclennan Companies (MMC – Research Report) today and set a price ...

In a report released today, Nathan Race from Piper Sandler maintained a Hold rating on Commerce Bancshares (CBSH – Research Report), with a ...

Wingstop (NASDAQ:WING – Get Free Report) was upgraded by research analysts at Morgan Stanley from an “equal weight” rating to ...

Intra-Cellular Therapies Inc (ITCI) stock saw a modest uptick, ending the day at $126.5 which represents a slight increase of $0.30 or 0.24% from the prior close of $126.2. The stock opened at $126.64 ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 73.46% ...

Charles Schwab (NYSE:SCHW – Get Free Report) had its price objective upped by research analysts at Morgan Stanley from $74.00 ...

Discover three oversold biotech/biopharma stocks to watch amidst market volatility and the JP Morgan Healthcare event in San ...

Morgan Stanley (NYSE:MS) upgraded OneStream Inc. (NASDAQ: OS) stock rating from Equalweight to Overweight, setting a new ...

Kenneth Robert Bertram, Chief Legal Officer and Secretary of CAVA Group, Inc. (NYSE:CAVA), recently sold shares of the ...

"The combination of these factors makes rates the most important variable to watch in early 2025, in our view," Wilson wrote.

A renewed wave of dip buying fueled a rebound in stocks, following a selloff triggered by a recalibration of Federal Reserve wagers.

A strong December jobs report, signs of persistent inflation, and potential shifts in trade policy under the new ...